Hohl Benjamin — Insider Trades & Holdings | InsiderBid

Hohl Benjamin

Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: -$2M

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
ELVN	Enliven Therapeutics, Inc.	$0	$2M	-$2M	38,000	Sep 17

Enliven Therapeutics, Inc.

-$2M

Bought

$0

Sold

$2M

Held

38,000

Filing record

How quickly this filer reports. Section 16 allows two business days from the transaction.

All 15 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Trade history

The 51 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
Sep 17	ELVN	Enliven Therapeutics, Inc.	MEXER◷◆	3,982	—	—	—	Open the original filing on SEC.gov
Sep 17	ELVN	Enliven Therapeutics, Inc.	SSELL◷	289	$51.49

ELVNMEXER◷◆—

Enliven Therapeutics, Inc.Sep 17

3,982 sh

ELVNSSELL◷$14.9K

Enliven Therapeutics, Inc.Sep 17

289 sh @ $51.49 · -0.8% own

ELVNSSELL◷$111.3K

Enliven Therapeutics, Inc.Sep 17

2,194 sh @ $50.72 · -5.4% own

ELVNSSELL◷$176.9K

Enliven Therapeutics, Inc.Sep 17

3,535 sh @ $50.03 · -8.0% own

ELVNMEXER◷$59.1K

Enliven Therapeutics, Inc.Sep 17

3,982 sh @ $14.85 · +10.0% own

ELVNSSELL◷$82.4K

Enliven Therapeutics, Inc.Aug 17

1,388 sh @ $59.35 · -3.4% own

ELVNSSELL◷$270.2K

Enliven Therapeutics, Inc.Aug 17

4,630 sh @ $58.35 · -10.1% own

ELVNMEXER◷◆—

Enliven Therapeutics, Inc.Jul 17

1,072 sh

ELVNSSELL◷$6.6K

Enliven Therapeutics, Inc.Jul 17

123 sh @ $53.87 · -0.3% own

ELVNSSELL◷$140.8K

Enliven Therapeutics, Inc.Jul 17

2,638 sh @ $53.38 · -5.4% own

ELVNSSELL◷$134.1K

Enliven Therapeutics, Inc.Jul 17

2,564 sh @ $52.32 · -5.0% own

ELVNSSELL◷$19K

Enliven Therapeutics, Inc.Jul 17

369 sh @ $51.48 · -0.7% own

ELVNSSELL◷$16.2K

Enliven Therapeutics, Inc.Jul 17

324 sh @ $49.97 · -0.6% own

ELVNMEXER◷$2.7K

Enliven Therapeutics, Inc.Jul 17

1,072 sh @ $2.48 · +2.1% own

ELVNMEXER◷◆—

Enliven Therapeutics, Inc.Jun 17

6,018 sh

ELVNSSELL◷$55.4K

Enliven Therapeutics, Inc.Jun 17

1,238 sh @ $44.75 · -2.4% own

ELVNSSELL◷$149.2K

Enliven Therapeutics, Inc.Jun 17

3,401 sh @ $43.86 · -6.1% own

ELVNSSELL◷$59K

Enliven Therapeutics, Inc.Jun 17

1,379 sh @ $42.79 · -2.4% own

ELVNMEXER◷$14.9K

Enliven Therapeutics, Inc.Jun 17

6,018 sh @ $2.48 · +11.8% own

ELVNSSELL$295.8K

Enliven Therapeutics, Inc.Mar 6

10,000 sh @ $29.58 · -16.4% own

ELVNAGRANT◆—

Enliven Therapeutics, Inc.Feb 12

150,000 sh

ELVNAGRANT—

Enliven Therapeutics, Inc.Feb 12

25,000 sh · +69.4% own

ELVNMEXER◆—

Enliven Therapeutics, Inc.Dec 22, 2025

13,000 sh

ELVNMEXER$32.2K

Enliven Therapeutics, Inc.Dec 22, 2025

13,000 sh @ $2.48 · +56.5% own

ELVNMEXER◷◆—

Enliven Therapeutics, Inc.Sep 29, 2025

3,250 sh

ELVNSSELL◷$66.3K

Enliven Therapeutics, Inc.Sep 29, 2025

3,250 sh @ $20.40 · -12.4% own

ELVNMEXER◷$8.1K

Enliven Therapeutics, Inc.Sep 29, 2025

3,250 sh @ $2.48 · +14.1% own

ELVNMEXER◷◆—

Enliven Therapeutics, Inc.Aug 27, 2025

3,250 sh

ELVNSSELL◷$67K

Enliven Therapeutics, Inc.Aug 27, 2025

3,250 sh @ $20.63 · -12.4% own

ELVNMEXER◷$8.1K

Enliven Therapeutics, Inc.Aug 27, 2025

3,250 sh @ $2.48 · +14.1% own

ELVNMEXER◷◆—

Enliven Therapeutics, Inc.Jul 28, 2025

3,250 sh

ELVNSSELL◷$1.4K

Enliven Therapeutics, Inc.Jul 28, 2025

65 sh @ $21.30 · -0.3% own

ELVNSSELL◷$65.1K

Enliven Therapeutics, Inc.Jul 28, 2025

3,185 sh @ $20.45 · -12.1% own

ELVNMEXER◷$8.1K

Enliven Therapeutics, Inc.Jul 28, 2025

3,250 sh @ $2.48 · +14.1% own

ELVNMEXER◷◆—

Enliven Therapeutics, Inc.Jul 10, 2025

1,000 sh

ELVNSSELL◷$22.7K

Enliven Therapeutics, Inc.Jul 10, 2025

1,000 sh @ $22.66 · -4.2% own

ELVNMEXER◷$2.5K

Enliven Therapeutics, Inc.Jul 10, 2025

1,000 sh @ $2.48 · +4.3% own

ELVNMEXER◷◆—

Enliven Therapeutics, Inc.Jun 27, 2025

3,250 sh

ELVNSSELL◷$4.3K

Enliven Therapeutics, Inc.Jun 27, 2025

198 sh @ $21.66 · -0.9% own

ELVNSSELL◷$63.7K

Enliven Therapeutics, Inc.Jun 27, 2025

3,052 sh @ $20.86 · -11.6% own

ELVNMEXER◷$8.1K

Enliven Therapeutics, Inc.Jun 27, 2025

3,250 sh @ $2.48 · +14.1% own

ELVNMEXER◷◆—

Enliven Therapeutics, Inc.Jun 13, 2025

3,000 sh

ELVNSSELL◷$67.7K

Enliven Therapeutics, Inc.Jun 13, 2025

3,000 sh @ $22.55 · -11.5% own

ELVNMEXER◷$7.4K

Enliven Therapeutics, Inc.Jun 13, 2025

3,000 sh @ $2.48 · +13.0% own

ELVNMEXER◷◆—

Enliven Therapeutics, Inc.May 27, 2025

3,250 sh

ELVNSSELL◷$52.6K

Enliven Therapeutics, Inc.May 27, 2025

3,250 sh @ $16.18 · -12.4% own

ELVNMEXER◷$8.1K

Enliven Therapeutics, Inc.May 27, 2025

3,250 sh @ $2.48 · +14.1% own

ELVNMEXER◷◆—

Enliven Therapeutics, Inc.Apr 28, 2025

3,250 sh

ELVNSSELL◷$1.3K

Enliven Therapeutics, Inc.Apr 28, 2025

69 sh @ $19.12 · -0.3% own

ELVNSSELL◷$59.4K

Enliven Therapeutics, Inc.Apr 28, 2025

3,181 sh @ $18.68 · -12.1% own

ELVNMEXER◷$8.1K

Enliven Therapeutics, Inc.Apr 28, 2025

3,250 sh @ $2.48 · +14.1% own